Advertisement

Topics

Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500

10:29 EDT 5 Jul 2017 | BioPortfolio Report Blog

Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017, provides an overview of the Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology pipeline landscape.

Malignant peripheral nerve sheath tumors MPNSTs are sarcomas which originate from peripheral nerves or from cells associated with the nerve sheath, such as Schwann cells, perineural cells, or fibroblasts. Symptoms include lump or swelling in the in the soft tissue, numbness, burning or having that pins and needles feeling, weakness in the affected muscles and dizziness or loss of balance. Treatment includes surgery, radiotherapy and chemotherapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology pipeline guide also reviews of key players involved in therapeutic development for Peripheral Nerve Sheath Tumor Neurofibrosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Phase I stages are 7 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology.
The pipeline guide reviews pipeline therapeutics for Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology by companies and universities/research institutes based on information derived from company and industryspecific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.
The pipeline guide reviews key companies involved in Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.
Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology.
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Peripheral Nerve Sheath Tumor Neurofibrosarcoma Oncology pipeline depth and focus of Indication therapeutics.
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Peripheral Nerve Sheath Tumor Neurofibrosarcoma Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...